Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate

被引:153
作者
Kuo, CJ
Chi, YH
Hsu, JTA
Liang, PH [1 ]
机构
[1] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan
[2] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei 115, Taiwan
关键词
SARS protease; chymotrypsin; cysteine protease; fluorescence resonance energy transfer; fluorogenic substrate; inhibitor screening;
D O I
10.1016/j.bbrc.2004.04.098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS main protease is essential for life cycle of SARS coronavirus and may be a key target for developing anti-SARS drugs. Recently, the enzyme expressed in Escherichia coli was characterized using a HPLC assay to monitor the formation of products from 11 peptide substrates covering the cleavage sites found in the SARS. viral genome. This protease easily dissociated into inactive monomer and the deduced K-d of the dimer was 100 muM. In order to detect enzyme activity, the assay needed to be performed at micromolar enzyme concentration. This makes finding the tight inhibitor (nanomolar range IC50) impossible. In this study, we prepared a peptide with fluorescence quenching pair (Dabcyl and Edans) at both ends of a peptide substrate and used this fluorogenic peptide substrate to characterize SARS main protease and screen inhibitors. The fluorogenic peptide gave extremely sensitive signal upon cleavage catalyzed by the protease. Using this substrate, the protease exhibits a significantly higher activity (k(cat) = 1.9 s(-1) and K-m = 17 muM) compared to the previously reported parameters. Under our assay condition, the enzyme stays as an active dimer without dissociating into monomer and reveals a small Kd value (15 nM). This enzyme in conjunction with fluorogenic peptide substrate provides us a suitable tool for identifying potent inhibitors of SARS protease. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:862 / 867
页数:6
相关论文
共 21 条
  • [1] Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
    Anand, K
    Ziebuhr, J
    Wadhwani, P
    Mesters, JR
    Hilgenfeld, R
    [J]. SCIENCE, 2003, 300 (5626) : 1763 - 1767
  • [2] Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain
    Anand, K
    Palm, GJ
    Mesters, JR
    Siddell, SG
    Ziebuhr, J
    Hilgenfeld, R
    [J]. EMBO JOURNAL, 2002, 21 (13) : 3213 - 3224
  • [3] Probing the conformational change of Escherichia coli undecaprenyl pyrophosphate synthase during catalysis using an inhibitor and tryptophan mutants
    Chen, YH
    Chen, APC
    Chen, CT
    Wang, AHJ
    Liang, PH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) : 7369 - 7376
  • [4] Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS
    Chou, KC
    Wei, DQ
    Zhong, WZ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (01) : 148 - 151
  • [5] Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors
    Dales, NA
    Gould, AE
    Brown, JA
    Calderwood, EF
    Guan, B
    Minor, CA
    Gavin, JM
    Hales, P
    Kaushik, VK
    Stewart, M
    Tummino, PJ
    Vickers, CS
    Ocain, TD
    Patane, MA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (40) : 11852 - 11853
  • [6] Identification of a novel coronavirus in patients with severe acute respiratory syndrome
    Drosten, C
    Günther, S
    Preiser, W
    van der Werf, S
    Brodt, HR
    Becker, S
    Rabenau, H
    Panning, M
    Kolesnikova, L
    Fouchier, RAM
    Berger, A
    Burguière, AM
    Cinatl, J
    Eickmann, M
    Escriou, N
    Grywna, K
    Kramme, S
    Manuguerra, JC
    Müller, S
    Rickerts, V
    Stürmer, M
    Vieth, S
    Klenk, HD
    Osterhaus, ADME
    Schmitz, H
    Doerr, HW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) : 1967 - 1976
  • [7] Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase
    Fan, KQ
    Wei, P
    Feng, Q
    Chen, SD
    Huang, CK
    Ma, L
    Lai, B
    Pei, JF
    Liu, Y
    Chen, JG
    Lai, LH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (03) : 1637 - 1642
  • [8] Aetiology -: Koch's postulates fulfilled for SARS virus
    Fouchier, RAM
    Kuiken, T
    Schutten, M
    van Amerongen, G
    van Doornum, J
    van den Hoogen, BG
    Peiris, M
    Lim, W
    Stöhr, K
    Osterhaus, ADME
    [J]. NATURE, 2003, 423 (6937) : 240 - 240
  • [9] Novel peptide inhibitors of angiotensin-converting enzyme 2
    Huang, LL
    Sexton, DJ
    Skogerson, K
    Devlin, M
    Smith, R
    Sanyal, I
    Parry, T
    Kent, R
    Enright, J
    Wu, QL
    Conley, G
    DeOliveira, D
    Morganelli, L
    Ducar, M
    Wescott, CR
    Ladner, RC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) : 15532 - 15540
  • [10] Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods
    Khayat, R
    Batra, R
    Bebernitz, GA
    Olson, MW
    Tong, L
    [J]. BIOCHEMISTRY, 2004, 43 (02) : 316 - 322